English

GLOBUS MEDICAL, INC.

EDGAR

GMED Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 2.939B, using the latest reported figures. The previous period, 2024, was about USD 2.519B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

790 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 789612000 USD Source

Operating margin

23.1%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 182432000 USD Source
Revenue: 789612000 USD Source

Operating cash flow

210 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 412105000 USD Source
Operating Cash Flow: 202364000 USD Source

Free cash flow

177 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 412105000 USD Source
Operating Cash Flow: 202364000 USD Source
Capital Expenditure: 72783000 USD Source
Capital Expenditure: 39615000 USD Source

Cash and cash equivalents: 508 million USD 2026-06-30 Source
Exact value

507745000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 97.8 million Unit1 2020-06-30 Source
Exact value

97756815 Unit1

Reported share-count change

-1.33% · -1.32 million Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

99077550 Unit1 · 2019-06-30· Source
97756815 Unit1 · 2020-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2025-12-31
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+16.7%

Prior period

USD 2.52 billion

2024-01-01 – 2024-12-31
Current period

USD 2.94 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

2938931000 − 2519355000 = 419576000 USD

2519355000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2938931000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Year-over-year change in Revenue: 419576000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2938931000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#2269277 Filing: 000162828026011209 Input fundies:Revenue: 2519355000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#2270230 Filing: 000162828026011209
The citation records this snapshot. The page link may show a newer release later.
Net income
+422.3%

Prior period

USD 102.98 million

2024-01-01 – 2024-12-31
Current period

USD 537.87 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

537868000 − 102984000 = 434884000 USD

102984000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
537868000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Year-over-year change in Net income: 434884000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 537868000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1182853 Filing: 000162828026011209 Input fundies:NetIncome: 102984000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1183738 Filing: 000162828026011209
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+44.7%

Prior period

USD 520.64 million

2024-01-01 – 2024-12-31
Current period

USD 753.45 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

753447000 − 520638000 = 232809000 USD

520638000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
753447000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Year-over-year change in Operating cash flow: 232809000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 753447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1224597 Filing: 000162828026011209 Input fundies:OperatingCashFlow: 520638000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1225368 Filing: 000162828026011209
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+42.7%

Prior period

USD 115.43 million

2024-01-01 – 2024-12-31
Current period

USD 164.68 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

164679000 − 115429000 = 49250000 USD

115429000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
164679000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Year-over-year change in Capital expenditure: 49250000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 164679000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1233856 Filing: 000162828026011209 Input fundies:CapitalExpenditure: 115429000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1234447 Filing: 000162828026011209
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 2.94 billion 100% of revenue
Cost of revenue USD 957.8 million 33% of revenue
Operating expenses USD 1.33 billion 45% of revenue
Other operating costs Derived USD 175.57 million 6% of revenue
Operating income USD 479.82 million 16% of revenue
Tax, interest and other Derived −USD 58.05 million −2% of revenue
Net income USD 537.87 million 18% of revenue

Cash

Operating cash flow USD 753.45 million 26% of revenue
Capital expenditure USD 164.68 million 5.6% of revenue
Free cash flow Derived USD 588.77 million 20% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 21%11%68%
2016 19%73%
2017 17%75%
2018 22%76%
2023 92%
2024 93%
2025 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	544753000	372531000 Derived	172222000	59438000 Derived	112784000	73247000 Derived	Source 2015-01-01 – 2015-12-31: 544753000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 172222000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 112784000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 124007000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 50760000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	563994000	409853000 Derived	154141000	49800000 Derived	104341000	106914000 Derived	Source 2016-01-01 – 2016-12-31: 563994000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 154141000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 104341000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 147823000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 40909000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	635977000	474137000 Derived	161840000	54492000 Derived	107348000	107755000 Derived	Source 2017-01-01 – 2017-12-31: 635977000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 161840000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 107348000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 159058000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 51303000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	712969000	543644000 Derived	169325000	12851000 Derived	156474000	121946000 Derived	Source 2018-01-01 – 2018-12-31: 712969000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 169325000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 156474000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 181643000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 59697000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1568476000	1435334000 Derived	133142000	10269000 Derived	122873000	165225000 Derived	Source 2023-01-01 – 2023-12-31: 1568476000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 133142000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 122873000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 243499000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 78274000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2519355000	2353364000 Derived	165991000	63007000 Derived	102984000	405209000 Derived	Source 2024-01-01 – 2024-12-31: 2519355000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 165991000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 102984000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 520638000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 115429000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	2938931000	2459115000 Derived	479816000	-58052000 Derived	537868000	588768000 Derived	Source 2025-01-01 – 2025-12-31: 2938931000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 479816000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 537868000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 753447000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 164679000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.9B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	544753000	Revenue: 544753000 Open source
20162016-12-31	Revenue	563994000	Revenue: 563994000 Open source
20172017-12-31	Revenue	635977000	Revenue: 635977000 Open source
20182018-12-31	Revenue	712969000	Revenue: 712969000 Open source
20232023-12-31	Revenue	1568476000	Revenue: 1568476000 Open source
20242024-12-31	Revenue	2519355000	Revenue: 2519355000 Open source
20252025-12-31	Revenue	2938931000	Revenue: 2938931000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

16.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 544753000 Open source
20162016-12-31	Year over year	3.5%	Revenue: 563994000 Open source Revenue: 544753000 Open source
20172017-12-31	Year over year	12.8%	Revenue: 635977000 Open source Revenue: 563994000 Open source
20182018-12-31	Year over year	12.1%	Revenue: 712969000 Open source Revenue: 635977000 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 1568476000 Open source
20242024-12-31	Year over year	60.6%	Revenue: 2519355000 Open source Revenue: 1568476000 Open source
20252025-12-31	Year over year	16.7%	Revenue: 2938931000 Open source Revenue: 2519355000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 16.3% 2025

Net margin 18.3% 2025

Free cash flow margin 20% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	31.6%	Operating Income: 172222000 Open source Revenue: 544753000 Open source
20162016-12-31	Operating margin	27.3%	Operating Income: 154141000 Open source Revenue: 563994000 Open source
20172017-12-31	Operating margin	25.4%	Operating Income: 161840000 Open source Revenue: 635977000 Open source
20182018-12-31	Operating margin	23.7%	Operating Income: 169325000 Open source Revenue: 712969000 Open source
20232023-12-31	Operating margin	8.5%	Operating Income: 133142000 Open source Revenue: 1568476000 Open source
20242024-12-31	Operating margin	6.6%	Operating Income: 165991000 Open source Revenue: 2519355000 Open source
20252025-12-31	Operating margin	16.3%	Operating Income: 479816000 Open source Revenue: 2938931000 Open source
20152015-12-31	Net margin	20.7%	Net Income: 112784000 Open source Revenue: 544753000 Open source
20162016-12-31	Net margin	18.5%	Net Income: 104341000 Open source Revenue: 563994000 Open source
20172017-12-31	Net margin	16.9%	Net Income: 107348000 Open source Revenue: 635977000 Open source
20182018-12-31	Net margin	21.9%	Net Income: 156474000 Open source Revenue: 712969000 Open source
20232023-12-31	Net margin	7.8%	Net Income: 122873000 Open source Revenue: 1568476000 Open source
20242024-12-31	Net margin	4.1%	Net Income: 102984000 Open source Revenue: 2519355000 Open source
20252025-12-31	Net margin	18.3%	Net Income: 537868000 Open source Revenue: 2938931000 Open source
20152015-12-31	Free cash flow margin	13.4%	Revenue: 544753000 Open source Operating Cash Flow: 124007000 Open source Capital Expenditure: 50760000 Open source
20162016-12-31	Free cash flow margin	19%	Revenue: 563994000 Open source Operating Cash Flow: 147823000 Open source Capital Expenditure: 40909000 Open source
20172017-12-31	Free cash flow margin	16.9%	Revenue: 635977000 Open source Operating Cash Flow: 159058000 Open source Capital Expenditure: 51303000 Open source
20182018-12-31	Free cash flow margin	17.1%	Revenue: 712969000 Open source Operating Cash Flow: 181643000 Open source Capital Expenditure: 59697000 Open source
20232023-12-31	Free cash flow margin	10.5%	Revenue: 1568476000 Open source Operating Cash Flow: 243499000 Open source Capital Expenditure: 78274000 Open source
20242024-12-31	Free cash flow margin	16.1%	Revenue: 2519355000 Open source Operating Cash Flow: 520638000 Open source Capital Expenditure: 115429000 Open source
20252025-12-31	Free cash flow margin	20%	Revenue: 2938931000 Open source Operating Cash Flow: 753447000 Open source Capital Expenditure: 164679000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 753.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	124007000	Operating Cash Flow: 124007000 Open source
20162016-12-31	Operating cash flow	147823000	Operating Cash Flow: 147823000 Open source
20172017-12-31	Operating cash flow	159058000	Operating Cash Flow: 159058000 Open source
20182018-12-31	Operating cash flow	181643000	Operating Cash Flow: 181643000 Open source
20232023-12-31	Operating cash flow	243499000	Operating Cash Flow: 243499000 Open source
20242024-12-31	Operating cash flow	520638000	Operating Cash Flow: 520638000 Open source
20252025-12-31	Operating cash flow	753447000	Operating Cash Flow: 753447000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 588.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	73247000	Operating Cash Flow: 124007000 Open source Capital Expenditure: 50760000 Open source
20162016-12-31	Free cash flow	106914000	Operating Cash Flow: 147823000 Open source Capital Expenditure: 40909000 Open source
20172017-12-31	Free cash flow	107755000	Operating Cash Flow: 159058000 Open source Capital Expenditure: 51303000 Open source
20182018-12-31	Free cash flow	121946000	Operating Cash Flow: 181643000 Open source Capital Expenditure: 59697000 Open source
20232023-12-31	Free cash flow	165225000	Operating Cash Flow: 243499000 Open source Capital Expenditure: 78274000 Open source
20242024-12-31	Free cash flow	405209000	Operating Cash Flow: 520638000 Open source Capital Expenditure: 115429000 Open source
20252025-12-31	Free cash flow	588768000	Operating Cash Flow: 753447000 Open source Capital Expenditure: 164679000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

13.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	14.2%	Total Liabilities: 118776000 Open source Total Assets: 834100000 Open source
20162016-12-31	Liabilities / assets	10.3%	Total Liabilities: 95559000 Open source Total Assets: 927637000 Open source
20172017-12-31	Liabilities / assets	10.3%	Total Liabilities: 110724000 Open source Total Assets: 1078502000 Open source
20182018-12-31	Liabilities / assets	8.9%	Total Liabilities: 115154000 Open source Total Assets: 1300670000 Open source
2023-12-31	Liabilities / assets	Not reported	No source recorded
20242024-12-31	Liabilities / assets	20.5%	Total Liabilities: 1074417000 Open source Total Assets: 5251750000 Open source
20252025-12-31	Liabilities / assets	13.8%	Total Liabilities: 729511000 Open source Total Assets: 5302761000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.26× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	6.59×	Current Assets: 544799000 Open source Current Liabilities: 82691000 Open source
20162016-12-31	Current assets / current liabilities	6.43×	Current Assets: 513766000 Open source Current Liabilities: 79892000 Open source
20172017-12-31	Current assets / current liabilities	6.67×	Current Assets: 620342000 Open source Current Liabilities: 93073000 Open source
20182018-12-31	Current assets / current liabilities	6.56×	Current Assets: 630681000 Open source Current Liabilities: 96118000 Open source
2023-12-31	Current assets / current liabilities	Not reported	No source recorded
20242024-12-31	Current assets / current liabilities	2.54×	Current Assets: 2177260000 Open source Current Liabilities: 855913000 Open source
20252025-12-31	Current assets / current liabilities	4.26×	Current Assets: 2125611000 Open source Current Liabilities: 498499000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	USD 112.78 million Exact value Exact value: 112784000 USD 2015-01-01 – 2015-12-31: 112784000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2015-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 112784000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 112784000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783118000012/gmed-20171231.xml#365455 Filing: 000123783118000012 The citation records this snapshot. The page link may show a newer release later.	USD 124.01 million Exact value Exact value: 124007000 USD 2015-01-01 – 2015-12-31: 124007000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2015-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 124007000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 124007000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783118000012/gmed-20171231.xml#364819 Filing: 000123783118000012 The citation records this snapshot. The page link may show a newer release later.	USD 50.76 million Exact value Exact value: 50760000 USD 2015-01-01 – 2015-12-31: 50760000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2015-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 50760000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50760000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783118000012/gmed-20171231.xml#382602 Filing: 000123783118000012 The citation records this snapshot. The page link may show a newer release later.	USD 73.25 million Calculation and evidence 124007000 − 50760000 USD Exact free cash flow: 73247000 USD 2015-01-01 – 2015-12-31: 124007000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 50760000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2015-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 73247000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 124007000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783118000012/gmed-20171231.xml#364819 Filing: 000123783118000012 Input fundies:CapitalExpenditure: 50760000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783118000012/gmed-20171231.xml#382602 Filing: 000123783118000012 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 104.34 million Exact value Exact value: 104341000 USD 2016-01-01 – 2016-12-31: 104341000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2016-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 104341000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 104341000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372662 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 147.82 million Exact value Exact value: 147823000 USD 2016-01-01 – 2016-12-31: 147823000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2016-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 147823000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 147823000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372026 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 40.91 million Exact value Exact value: 40909000 USD 2016-01-01 – 2016-12-31: 40909000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2016-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 40909000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 40909000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#389945 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 106.91 million Calculation and evidence 147823000 − 40909000 USD Exact free cash flow: 106914000 USD 2016-01-01 – 2016-12-31: 147823000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 40909000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2016-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 106914000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 147823000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372026 Filing: 000123783119000014 Input fundies:CapitalExpenditure: 40909000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#389945 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 107.35 million Exact value Exact value: 107348000 USD 2017-01-01 – 2017-12-31: 107348000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2017-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 107348000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 107348000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#373428 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 159.06 million Exact value Exact value: 159058000 USD 2017-01-01 – 2017-12-31: 159058000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2017-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 159058000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 159058000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372238 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 51.3 million Exact value Exact value: 51303000 USD 2017-01-01 – 2017-12-31: 51303000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2017-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 51303000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51303000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#390156 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 107.76 million Calculation and evidence 159058000 − 51303000 USD Exact free cash flow: 107755000 USD 2017-01-01 – 2017-12-31: 159058000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 51303000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2017-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 107755000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 159058000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372238 Filing: 000123783119000014 Input fundies:CapitalExpenditure: 51303000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#390156 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 156.47 million Exact value Exact value: 156474000 USD 2018-01-01 – 2018-12-31: 156474000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2018-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 156474000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 156474000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#374194 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 181.64 million Exact value Exact value: 181643000 USD 2018-01-01 – 2018-12-31: 181643000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2018-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 181643000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 181643000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372450 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 59.7 million Exact value Exact value: 59697000 USD 2018-01-01 – 2018-12-31: 59697000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2018-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 59697000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59697000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#390367 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.	USD 121.95 million Calculation and evidence 181643000 − 59697000 USD Exact free cash flow: 121946000 USD 2018-01-01 – 2018-12-31: 181643000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 59697000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2018-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 121946000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 181643000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#372450 Filing: 000123783119000014 Input fundies:CapitalExpenditure: 59697000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed-20181231.xml#390367 Filing: 000123783119000014 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 122.87 million Exact value Exact value: 122873000 USD 2023-01-01 – 2023-12-31: 122873000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2023-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 122873000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 122873000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1184506 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 243.5 million Exact value Exact value: 243499000 USD 2023-01-01 – 2023-12-31: 243499000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2023-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 243499000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 243499000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1226022 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 78.27 million Exact value Exact value: 78274000 USD 2023-01-01 – 2023-12-31: 78274000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2023-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 78274000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 78274000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1235039 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 165.23 million Calculation and evidence 243499000 − 78274000 USD Exact free cash flow: 165225000 USD 2023-01-01 – 2023-12-31: 243499000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 78274000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2023-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 165225000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 243499000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1226022 Filing: 000162828026011209 Input fundies:CapitalExpenditure: 78274000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1235039 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 102.98 million Exact value Exact value: 102984000 USD 2024-01-01 – 2024-12-31: 102984000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2024-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 102984000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 102984000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1183738 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 520.64 million Exact value Exact value: 520638000 USD 2024-01-01 – 2024-12-31: 520638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2024-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 520638000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 520638000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1225368 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 115.43 million Exact value Exact value: 115429000 USD 2024-01-01 – 2024-12-31: 115429000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2024-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 115429000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 115429000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1234447 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 405.21 million Calculation and evidence 520638000 − 115429000 USD Exact free cash flow: 405209000 USD 2024-01-01 – 2024-12-31: 520638000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 115429000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2024-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 405209000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 520638000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1225368 Filing: 000162828026011209 Input fundies:CapitalExpenditure: 115429000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1234447 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 537.87 million Exact value Exact value: 537868000 USD 2025-01-01 – 2025-12-31: 537868000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Net Income: 537868000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 537868000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1182853 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 753.45 million Exact value Exact value: 753447000 USD 2025-01-01 – 2025-12-31: 753447000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Operating Cash Flow: 753447000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 753447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1224597 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 164.68 million Exact value Exact value: 164679000 USD 2025-01-01 – 2025-12-31: 164679000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Capital Expenditure: 164679000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 164679000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1233856 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.	USD 588.77 million Calculation and evidence 753447000 − 164679000 USD Exact free cash flow: 588768000 USD 2025-01-01 – 2025-12-31: 753447000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 164679000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBUS MEDICAL, INC. · 2025-12-31 GLOBUS MEDICAL, INC. (edgar:1237831) Free cash flow: 588768000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1237831?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 753447000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1224597 Filing: 000162828026011209 Input fundies:CapitalExpenditure: 164679000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm#1233856 Filing: 000162828026011209 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 5,655 latest values · 5,655 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001237831, 1237831, GMED, edgar:1237831

Also known as GLOBUS MEDICAL INC, GLOBUS MEDICAL, INC.

GLOBUS MEDICAL, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation